Aqr Capital Management LLC Precision Biosciences Inc Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.15 - $3.34 $12,705 - $36,900
-11,048 Reduced 5.09%
206,080 $330,000
Q1 2022

May 16, 2022
BUY
$2.96 - $7.76 $574,781 - $1.51 Million
194,183 Added 846.3%
217,128 $669,000
Q4 2021

Feb 14, 2022
BUY
$7.4 - $11.66 $169,793 - $267,538
22,945 New
22,945 $170,000
Q4 2020

Feb 16, 2021
SELL
$5.98 - $12.47 $79,217 - $165,190
-13,247 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$4.65 - $8.73 $61,598 - $115,646
13,247 New
13,247 $82,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $526M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email